Immune recognition and rejection of allogeneic skin grafts

Immunotherapy

Volumn 3, Issue 6, 2011, Pages 757-770

  Benichou, Gilles ^a   Yamada, Yohei ^a   Yun, Seok Hyun ^a   Lin, Charles ^a   Fray, Michael ^a   Tocco, Georges ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

allorecognition; B lymphocytes; NK cells; passenger leukocytes; skin transplantation; T lymphocytes; transplant rejection

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LANGERHANS CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN ALLOGRAFT; SKIN BLOOD FLOW; SKIN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; LYMPHOCYTES; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959275946     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.11.2     Document Type: Review

References (132)

1. Billingham RE, Medawar PD: The technique of free skin grafting in mammals. J. Exp. Biol. 28, 385 (1951).
2. Billingham RE, Brent L, Medawar PB: Activity acquired tolerance of foreign cells. Nature 172(4379), 603-606 (1953).
3. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10, 333-358 (1992).
4. Hunger RE, Sieling PA, Ochoa MT et al.: Langerhans cells utilize CD1A and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113(5), 701-708 (2004). (Pubitemid 38544163)
5. Valladeau J, Ravel O, Dezutter-Dambuyant C et al.: Langerin, a novel c-type lectin specific to langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12(1), 71-81 (2000). (Pubitemid 30069216)
6. Merad M, Manz MG, Karsunky H et al.: Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3(12), 1135-1141 (2002). (Pubitemid 35469697)
7. Liu K, Victora GD, Schwickert TA et al.: In vivo analysis of dendritic cell development and homeostasis. Science 324(5925), 392-397 (2009).
8. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M: Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8(6), 578-583 (2007). (Pubitemid 46785121)
9. Liu YJ, Soumelis V, Watanabe N et al.: TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25, 193-219 (2007). (Pubitemid 46697907)
10. + DCS. J. Exp. Med. 206(13), 3115-3130 (2009).
11. Vishwanath M, Nishibu A, Saeland S et al.: Development of intravital intermittent confocal imaging system for studying langerhans cell turnover. J. Invest. Dermatol. 126(11), 2452-2457 (2006). (Pubitemid 44582267)
12. Kamath AT, Henri S, Battye F, Tough DF, Shortman K: Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100(5), 1734-1741 (2002). (Pubitemid 34925152)
13. + cells differentiate into langerhans cells. Nat. Immunol. 2(12), 1151-1158 (2001). (Pubitemid 33130150)
14. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B: Cutaneous CXCL14 targets blood precursors to epidermal niches for langerhans cell differentiation. Immunity 23(3), 331-342 (2005). (Pubitemid 41317799)
15. Merad M, Hoffmann P, Ranheim E et al.: Depletion of host langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10(5), 510-517 (2004). (Pubitemid 38667910)
16. Chorro L, Sarde A, Li M et al.: Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 206(13), 3089-3100 (2009).
17. Merad M, Ginhoux F, Collin M: Origin, homeostasis and function of langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8(12), 935-947 (2008).
18. + dendritic cells survey the skin in the steady state. J. Exp. Med. 204(13), 3133-3146 (2007).
19. + dendritic cells that develop and function independently of epidermal langerhans cells. J. Exp. Med. 204(13), 3119-3131 (2007).
20. + T cell proliferation in vivo. J. Immunol. 181(1), 418-430 (2008).
21. Morikawa Y, Tohya K, Ishida H, Matsuura N, Kakudo K: Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice. Immunology 85(4), 575-581 (1995).
22. Van Wilsem EJ, Breve J, Kleijmeer M, Kraal G: Antigen-bearing langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration. J. Invest. Dermatol. 103(2), 217-220 (1994). (Pubitemid 24234611)
23. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C: Evidence that cutaneous antigenpresenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145(9), 2833-2838 (1990). (Pubitemid 20382549)
24. Hoefakker S, Balk HP, Boersma WJ, Van Joost T, Notten WR, Claassen E: Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization. Immunology 86(2), 296-303 (1995).
25. Richters CD, Van Pelt AM, Van Geldrop E et al.: Migration of rat skin dendritic cells. J. Leukoc. Biol. 60(3), 317-322 (1996). (Pubitemid 26325612)
26. Richters CD, Van Gelderop E, Du Pont JS, Hoekstra MJ, Kreis RW, Kamperdijk EW: Migration of dendritic cells to the draining lymph node after allogeneic or congeneic rat skin transplantation. Transplantation 67(6), 828-832 (1999). (Pubitemid 29169127)
27. Larsen CP, Morris PJ, Austyn JM: Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171(1), 307-314 (1990).
28. Larsen CP, Morris PJ, Austyn JM: Donor dendritic leukocytes migrate from cardiac allografts into recipients' spleens. Transplant. Proc. 22(4), 1943-1944 (1990). (Pubitemid 20284609)
29. Larsen CP, Austyn JM: Langerhans cells migrate out of skin grafts and cultured skin: a model in which to study the mediators of dendritic leukocyte migration. Transplant. Proc. 23(1 Pt 1), 117-119 (1991).
30. Larsen CP, Austyn JM, Morris PJ: The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann. Surg. 212(3), 308-315; discussion 316-307 (1990).
31. Barker CF, Billingham RE: The role of afferent lymphatics in the rejection of skin homografts. J. Exp. Med. 128(1), 197-221 (1968).
32. Tilney NL, Gowans JL: Host sensitization by alymphatic skin allografts in the rat. Surg. Forum 21, 512-514 (1970).
33. Rogers NJ, Lechler RI: Allorecognition. Am. J. Transplant. 1(2), 97-102 (2001). (Pubitemid 33674147)
34. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH: The molecular basis of alloreactivity. Immunol. Today 11(3), 83-88 (1990). (Pubitemid 20062715)
35. Lechler R, Lombardi G: The structural basis of alloreactivity. Immunol. Res. 9(2), 135-146 (1990). (Pubitemid 20109687)
36. Lechler RI, Batchelor JR: Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J. Exp. Med. 156(6), 1835-1841 (1982). (Pubitemid 13167425)
37. Lechler RI, Batchelor JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155(1), 31-41 (1982). (Pubitemid 12209811)
38. Fangmann J, Dalchau R, Fabre JW: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175(6), 1521-1529 (1992).
39. Benichou G, Takizawa PA, Olson CA, Mcmillan M, Sercarz EE: Donor major histocompatibility complex (mhc) peptides are presented by recipient mhc molecules during graft rejection. J. Exp. Med. 175(1), 305-308 (1992).
40. Liu Z, Braunstein NS, Suciu-Foca N: T cell recognition of allopeptides in context of syngeneic mhc. J. Immunol. 148(1), 35-40 (1992).
41. Benichou G, Fedoseyeva E, Olson CA, Geysen HM, Mcmillan M, Sercarz EE: Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Int. Immunol. 6(1), 131-138 (1994).
42. Benichou G, Tam RC, Soares LR, Fedoseyeva EV: Indirect T-cell allorecognition: perspectives for peptidebased therapy in transplantation. Immunol. Today 18(2), 67-71 (1997). (Pubitemid 27107099)
43. Liu Z, Sun YK, Xi XYP et al.: Limited usage of T cell receptor V b genes by allopeptidespecific T cells. J. Immunol. 150(8 Pt 1), 3180-3186 (1993). (Pubitemid 23129696)
44. Liu Z, Colovai AI, Tugulea S et al.: Mapping of dominant HLA-DR determinants recognized via the indirect pathway. Transplant Proc. 29(1-2), 1014-1015 (1997). (Pubitemid 27126065)
45. Liu Z, Colovai AI, Tugulea S et al.: Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98(5), 1150-1157 (1996). (Pubitemid 26299928)
46. Warrens AN, Lombardi G, Lechler RI: Presentation and recognition of major and minor histocompatibility antigens. Transpl. Immunol. 2(2), 103-107 (1994). (Pubitemid 24228003)
47. Roopenian D, Choi EY, Brown A: The immunogenomics of minor histocompatibility antigens. Immunol. Rev. 190, 86-94 (2002). (Pubitemid 36071928)
48. Goulmy E: Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157, 125-140 (1997). (Pubitemid 27303125)
49. Goulmy E, Pool J, Van Lochem E, Volker-Dieben H: The role of human minor histocompatibility antigens in graft failure: a mini-review. Eye 9(Pt 2), 180-184 (1995).
50. Boisgerault F, Liu Y, Anosova N, Dana R, Benichou G: Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation 87(1), 16-23 (2009).
51. Arnold D, Faath S, Rammensee H, Schild H: Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182(3), 885-889 (1995).
52. Carbone FR, Bevan MJ: Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171(2), 377-387 (1990). (Pubitemid 20059033)
53. Heath WR, Carbone FR: Cytotoxic T lymphocyte activation by cross-priming. Curr. Opin. Immunol. 11(3), 314-318 (1999). (Pubitemid 29263960)
54. Matzinger P, Bevan MJ: Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol. 33(1), 92-100 (1977). (Pubitemid 8182057)
55. Breur-Vriesendorp BS, Ivanyi P: Selfrestricted primary human histocompatibility leukocyte antigen (HLA)-specific cytotoxic T lymphocytes. Intl Immunol. 5(1), 103-107 (1993). (Pubitemid 23038694)
56. Kievits F, Ivanyi P: A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. J. Exp. Med. 174(1), 15-19 (1991).
57. Kievits F, Ivanyi P: H-2 class I-restricted recognition of allogeneic class I peptides. Transplant. Proc. 25(1 Pt 1), 88 (1993). (Pubitemid 23082284)
58. + cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 60(12), 1621-1624 (1995).
59. + T cells are a prominent component of the allogeneic T-cell repertoire after skin graft rejection in mice. Transplantation 71(3), 418-421 (2001). (Pubitemid 32175979)
60. + T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3(9), 844-851 (2002).
61. Liu Z, Sun YK, Xi YP et al.: Limited usage of T cell receptor V b genes by allopeptide-specific T cells. J. Immunol. 150(8 Pt 1), 3180-3186 (1993). (Pubitemid 23129696)
62. Suciu-Foca N, Ciubotariu R, Liu Z, Ho E, Rose EA, Cortesini R: Persistent allopeptide reactivity and epitope spreading in chronic rejection. Transplant. Proc. 30(5), 2136-2137 (1998). (Pubitemid 28399453)
63. Ciubotariu R, Liu Z, Colovai AI et al.: Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J. Clin. Invest. 101(2), 398-405 (1998). (Pubitemid 28067337)
64. Suciu-Foca N, Ciubotariu R, Colovai A et al.: Persistent allopeptide reactivity and epitope spreading in chronic rejection. Transplant. Proc. 31(1-2), 100-101 (1999). (Pubitemid 29127378)
65. Boisgerault F, Anosova NG, Tam RC, Illigens BM, Fedoseyeva EV, Benichou G: Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum. Immunol. 61(12), 1352-1362 (2000). (Pubitemid 32102425)
66. Lehmann PV, Forsthuber T, Miller A, Sercarz EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358(6382), 155-157 (1992).
67. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G: Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14(5), 203-208 (1993). (Pubitemid 23124512)
68. Kaufman DL, Clare-Salzler M, Tian J et al.: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes [see comments]. Nature 366(6450), 69-72 (1993). (Pubitemid 23345238)
69. Suciu-Foca N, Ciubotariu R, Itescu S, Rose EA, Cortesini R: Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts. Transplant Proc. 30(8), 3999-4000 (1998). (Pubitemid 29013134)
70. Herrera OB, Golshayan D, Tibbott R et al.: A novel pathway of alloantigen presentation by dendritic cells. J. Immunol. 173(8), 4828-4837 (2004). (Pubitemid 39387763)
71. + T cells in vivo: the key to rational vaccine design. Annu. Rev. Immunol. 23, 651-682 (2005). (Pubitemid 40563182)
72. Gould DS, Auchincloss H Jr: Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20(2), 77-82 (1999). (Pubitemid 29136632)
73. Jiang S, Herrera O, Lechler RI: New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 16(5), 550-557 (2004). (Pubitemid 39165880)
74. Beuneu H, Garcia Z, Bousso P: Cutting edge: Cognate CD4 help promotes recruitment of antigen-specific CD8 T cells around dendritic cells. J. Immunol. 177(3), 1406-1410 (2006). (Pubitemid 44092471)
75. + T cells. Transplantation 54(2), 278-286 (1992).
76. + T cells in murine skin and heart allograft rejection across different antigenic desparities. Transpl. Immunol. 13(4), 297-304 (2004). (Pubitemid 39602597)
77. + T-cell memory via trail-mediated activation-induced cell death. Nature 434(7029), 88-93 (2005). (Pubitemid 40349390)
78. Zhang S, Zhang H, Zhao J: The role of CD4 T cell help for CD8 CTL activation. Biochem. Biophys. Res. Commun. 384(4), 405-408 (2009).
79. Curtsinger JM, Lins DC, Mescher MF: Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197(9), 1141-1151 (2003). (Pubitemid 36570069)
80. Joly E, Hudrisier D: What is trogocytosis and what is its purpose? Nat. Immunol. 4(9), 815 (2003). (Pubitemid 37098646)
81. Smyth LA, Harker N, Turnbull W et al.: The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J. Immunol. 181(5), 3212-3220 (2008).
82. Brown K, Sacks SH, Wong W: Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J. 22(11), 3776-3784 (2008).
83. Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2(8), 569-579 (2002). (Pubitemid 37328732)
84. + cells are essential for allorejection. J. Exp. Med. 184(5), 2013-2018 (1996). (Pubitemid 26404491)
85. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr: Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179(3), 865-872 (1994). (Pubitemid 24065644)
86. Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG: CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106(8), 1003-1010 (2000).
87. Bingaman AW, Farber DL: Memory T cells in transplantation: generation, function, and potential role in rejection. Am. J. Transplant. 4(6), 846-852 (2004). (Pubitemid 38745582)
88. Burrows SR, Silins SL, Khanna R et al.: Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 27(7), 1726-1736 (1997). (Pubitemid 27302856)
89. Valujskikh A: The challenge of inhibiting alloreactive T-cell memory. Am. J. Transplant. 6(4), 647-651 (2006). (Pubitemid 43345000)
90. Adams AB, Williams MA, Jones TR et al.: Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111(12), 1887-1895 (2003). (Pubitemid 38057733)
91. Taylor DK, Neujahr D, Turka LA: Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr. Opin. Immunol. 16(5), 558-564 (2004). (Pubitemid 39165881)
92. Nadazdin O, Boskovic S, Murakami T et al.: Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am. J. Transplant. 10(6), 1375-1384 (2010).
93. + cells stimulated indirectly, cause rejection of 'major histocompatibility complex-deficient' skin grafts. Transplantation 63(8), 1123-1133 (1997). (Pubitemid 27190976)
94. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH: The role of 'Indirect' Recognition in initiating rejection of skin grafts from major histocompatibility complex class ii-deficient mice. Proc. Natl Acad. Sci. USA 90(8), 3373-3377 (1993). (Pubitemid 23111368)
95. Watschinger B, Gallon L, Carpenter CB, Sayegh MH: Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 57(4), 572-576 (1994). (Pubitemid 24075805)
96. Liu Z, Sun YK, Xi YP et al.: Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177(6), 1643-1650 (1993). (Pubitemid 23146131)
97. Suciu-Foca N, Liu Z, Harris Pe et al.: Indirect recognition of native HLA alloantigens and B-cell help. Transplant. Proc. 27(1), 455-456 (1995).
98. Chen W, Murphy B, Waaga AM et al.: Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo. Transplantation 62(6), 705-710 (1996). (Pubitemid 26332829)
99. Fangmann J, Dalchau R, Fabre JW: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Transplant. Proc. 25(1 Pt 1), 183-184 (1993). (Pubitemid 23082321)
100. Valujskikh A, Matesic D, Gilliam A, Anthony D, Haqqi TM, Heeger PS: T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J. Clin. Invest. 101(6), 1398-1407 (1998). (Pubitemid 28145257)
101. + T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-γ. Transplantation 69(5), 1016-1019 (2000). (Pubitemid 30174142)
102. Koene RA, Gerlag PG, Jansen JJ, Hagemann JF, Wijdeveld PG: Rejection of skin grafts in the nude mouse. Nature 251(5470), 69-70 (1974).
103. Koene RA, Gerlag PG, Hagemann JF, Van Haelst UJ, Wijdeveld PG: Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement. J. Immunol. 111(2), 520-526 (1973).
104. De Waal RM, Capel PJ, Koene RA: The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts. J. Immunol. 124(2), 719-723 (1980). (Pubitemid 10146342)
105. Gerlag PG, Koene RA, Hagemann JF, Wijdeveld PG: Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement. Transplantation 20(4), 308-313 (1975).
106. Gerlag PG, Capel PJ, Hagemann JF, Koene RA: Adaptation of skin grafts in the mouse to antibody-mediated rejection. J. Immunol. 125(2), 583-586 (1980). (Pubitemid 10045630)
107. Jooste SV, Colvin RB, Soper WD, Winn HJ: The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum. J. Exp. Med. 154(5), 1319-1331 (1981). (Pubitemid 12235181)
108. Steele DJ, Laufer TM, Smiley ST et al.: Two levels of help for B cell alloantibody production. J. Exp. Med. 183(2), 699-703 (1996). (Pubitemid 26059527)
109. Ng YH, Oberbarnscheidt MH, Chandramoorthy HC, Hoffman R, Chalasani G: B cells help alloreactive t cells differentiate into memory T cells. Am. J. Transplant. 10(9), 1970-1980 (2010).
110. Hamerman JA, Ogasawara K, Lanier LL: NK cells in innate immunity. Curr. Opin. Immunol. 17(1), 29-35 (2005). (Pubitemid 40094010)
111. Lanier LL: NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005). (Pubitemid 40563170)
112. Yokoyama WM: The search for the missing 'missing-self ' receptor on natural killer cells. Scand. J. Immunol. 55(3), 233-237 (2002). (Pubitemid 34310027)
113. Yokoyama WM, Kim S: How do natural killer cells find self to achieve tolerance? Immunity 24(3), 249-257 (2006).
114. Yokoyama WM, Kim S, French AR: The dynamic life of natural killer cells. Annu. Rev. Immunol. 22, 405-429 (2004). (Pubitemid 38680428)
115. Bauer S, Groh V, Wu J et al.: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible mica. Science 285(5428), 727-729 (1999).
116. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH: Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413(6852), 165-171 (2001). (Pubitemid 32867877)
117. Mandelboim O, Lieberman N, Lev M et al.: Recognition of haemagglutinins on virusinfected cells by NKP46 activates lysis by human NK cells. Nature 409(6823), 1055-1060 (2001). (Pubitemid 32204059)
118. Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2- deficient lymphoma variants suggests alternative immune defence strategy. Nature 319(6055), 675-678 (1986). (Pubitemid 16119452)
119. Ljunggren HG, Karre K: In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol. Today 11(7), 237-244 (1990). (Pubitemid 20198988)
120. Biron CA, Brossay L: NK cells and NK T cells in innate defense against viral infections. Curr. Opin. Immunol. 13(4), 458-464 (2001). (Pubitemid 32728479)
121. Kiessling R, Klein E, Pross H, Wigzell H: 'Natural' killer cells in the mouse. II. Cytotoxic cells with specificity for mouse moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol. 5(2), 117-121 (1975).
122. Kiessling R, Klein E, Wigzell H: 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5(2), 112-117 (1975).
123. + IL-2-activated natural killer cells. Nature 358(6381), 66-70 (1992).
124. + IL-2-activated natural killer cells. J. Immunol. 177(9), 5761-5765 (2006).
125. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC: Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 112(3), 661-671 (2008).
126. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC: NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203(8), 1851-1858 (2006). (Pubitemid 44188459)
127. Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, Kaye PM: Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 29(2), 295-305 (2008).
128. + T cells. J. Immunol. 184(12), 6649-6657.
129. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donorspecific tolerance without myelosuppressive conditioning. Nat. Med. 3(7), 783-787 (1997). (Pubitemid 27298725)
130. Wekerle T, Sayegh MH, Hill J et al.: Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187(12), 2037-2044 (1998). (Pubitemid 28285573)
131. Wekerle T, Kurtz J, Ito H et al.: Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 6(4), 464-469 (2000). (Pubitemid 30208167)
132. Durham MM, Bingaman AW, Adams AB et al.: Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J. Immunol. 165(1), 1-4 (2000). (Pubitemid 30429481)